You are viewing the site in preview mode
Skip to main content
|
Effects
|
Influenza Vaccination
|
Cholinesterase Inhibitor Prescription
|
Benzodiazepine Prescription
|
Antipsychotic Prescription
|
|---|
|
Adjusted RRa (95% CI)
|
p-value
|
Adjusted RR (95% CI)
|
p-value
|
Adjusted RR (95% CI)
|
p-value
|
Adjusted RR (95% CI)
|
p-value
|
|---|
|
High visit frequency (> 7 visits/year)
|
1.32 (1.30 to 1.34)
|
< .0001
|
1.09 (1.07 to 1.12)
|
< .0001
|
1.74 (1.67 to 1.82)
|
< .0001
|
1.25 (1.19 to 1.30)
|
< .0001
|
|
High continuity of care
|
1.19 (1.16 to 1.21)
|
< .0001
|
1.47 (1.43 to 1.52)
|
< .0001
|
1.42 (1.35 to 1.49)
|
< .0001
|
1.31 (1.24 to 1.37)
|
< .0001
|
|
Long (≥ 5 years) doctor-patient relationship
|
1.14 (1.11 to 1.17)
|
< .0001
|
1.13 (1.10 to 1.16)
|
< .0001
|
1.04 (0.996 to 1.10)
|
0.08
|
0.89 (0.85 to 0.94)
|
< .0001
|
- Notes: aAll models were adjusted for the following confounders: patient age, sex, years since dementia diagnosis, CIHI Population Grouper category, urban/rural location of residence, neighborhood deprivation quintile, past 10-year immigration, and PCP daily patient volume, age, sex, years since graduation, Canadian medical graduate, urban/rural location of practice. Models of influenza vaccination were also adjusted for past-year hospitalization for COPD
